Endothelial microparticles and the diagnosis of the vasculitides

Internal Medicine

Volumn 43, Issue 12, 2004, Pages 1115-1119

  Brogan, Paul A ^a   Dillon, Michael J ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Child; Endothelial microparticles; Kawasaki disease; Polyarteritis nodosa; Vasculitis

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; LIPOCORTIN 5; MEMBRANE PHOSPHOLIPID;

ANGIOGRAPHY; BIOPSY TECHNIQUE; DIAGNOSTIC VALUE; DISEASE ACTIVITY; DISEASE CLASSIFICATION; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; FLOW CYTOMETRY; HUMAN; PATHOPHYSIOLOGY; PATIENT MONITORING; POLYARTERITIS NODOSA; RECEIVER OPERATING CHARACTERISTIC; REMISSION; REVIEW; SENSITIVITY AND SPECIFICITY; SYSTEMIC VASCULITIS;

BIOLOGICAL MARKERS; BLOOD PLATELETS; ENDOTHELIUM, VASCULAR; HUMANS; VASCULITIS;

EID: 11344290360     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.43.1115     Document Type: Review

References (35)

1. Brogan PA, Dillon MJ. Vasculitis from the pediatric perspective. Curr Rheumatol Rep 2: 411-416, 2000.
2. Sundy JS, Haynes BF. Cytokines and adhesion molecules in the pathogenesis of vasculitis. Curr Rheumatol Rep 2: 402-410, 2000.
3. Zwaal RF, Schroit AJ. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 89: 1121-1132, 1997.
4. Toti F, Satta N, Fressinaud E, Meyer D, Freyssinet JM. Scott syndrome, characterized by impaired transmembrane migration of procoagulant phosphatidylserine and hemorrhagic complications, is an inherited disorder. Blood 87: 1409-1415, 1996.
5. Comfurius P, Senden JM, Tilly RH, Schroit AJ, Bevers EM, Zwaal RF. Loss of membrane phospholipid asymmetry in platelets and red cells may be associated with calcium-induced shedding of plasma membrane and inhibition of aminophospholipid translocase. Biochim Biophys Acta 1026: 153-160, 1990.
6. Sims PJ, Wiedmer T, Esmon CT, Weiss HJ, Shattil SJ. Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: An isolated defect in platelet procoagulant activity. J Biol Chem 264: 17049-17057, 1989.
7. Wiedmer T, Shattil SJ, Cunningham M, Sims PJ. Role of calcium and calpain in complement-induced vesiculation of the platelet plasma membrane and in the exposure of the platelet factor Va receptor. Biochemistry 29: 623-632, 1990.
8. Jy W, Horstman LL, Wang F, Duncan RC, Ahn YS. Platelet factor 3 in plasma fractions: Its relation to microparticle size and thromboses. Thromb Res 80: 471-482, 1995.
9. Lee YJ, Jy W, Horstman LL, et al. Elevated platelet microparticles in transient ischemic attacks, lacunar infarcts, and multiinfarct dementias. Thromb Res 72: 295-304, 1993.
10. Jy W, Mao WW, Horstman L, Tao J, Ahn YS. Platelet microparticles bind, activate and aggregate neutrophils in vitro. Blood Cells Mol Dis 21: 217-231, 1995.
11. Hamilton KK, Hattori R, Esmon CT, Sims PJ. Complement proteins C5b-9 induce vesiculation of the endothelial plasma membrane and expose catalytic surface for assembly of the prothrombinase enzyme complex. J Biol Chem 265: 3809-3814, 1990.
12. Combes V, Simon AC, Grau GE, et al. In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. J Clin Invest 104: 93-102, 1999.
13. Jimenez JJ, Jy W, Mauro LM, Horstman LL, Ahn YS. Elevated endothelial microparticles in thrombotic thrombocytopenic purpura: Findings from brain and renal microvascular cell culture and patients with active disease. Br J Haematol 112: 81-90, 2001.
14. Minagar A, Jy W, Jimenez JJ, et al. Elevated plasma endothelial microparticles in multiple sclerosis. Neurology 56: 1319-1324, 2001.
15. Brogan PA, Shah V, Klein N, Dillon MJ. V-beta restricted T cell adherence to endothelial cells. A mechanism for superantigen-dependent vascular injury. Arthritis Rheum 50: 589-597, 2004.
16. Mallat Z, Hugel B, Ohan J, Leseche G, Freyssinet JM, Tedgui A. Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: A role for apoptosis in plaque thrombogenicity. Circulation 99: 348-353, 1999.
17. Mallat Z, Benamer H, Hugel B, et al. Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation 101: 841-843, 2000.
18. Preston RA, Jy W, Jimenez JJ, et al. Effects of severe hypertension on endothelial and platelet microparticles. Hypertension 41: 211-217, 2003.
19. Gonzalez-Quintero VH, Jimenez JJ, Jy W, et al. Elevated plasma endothelial microparticles in preeclampsia. Am J Obstet Gynecol 189: 589-593, 2003.
20. Brogan PA, Shah V, Brachet C, et al. Endothelial and platelet microparticles in vasculitis of the young. Arthritis Rheum 50: 927-936, 2004.
21. Berckmans RJ, Neiuwland R, Boing AN, Romijn FP, Hack CE, Sturk A. Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb Haemost 85: 639-646, 2001.
22. Joop K, Berckmans RJ, Nieuwland R, et al. Microparticles from patients with multiple organ dysfunction syndrome and sepsis support coagulation through multiple mechanisms. Thromb Haemost 85: 810-820, 2001.
23. Nieuwland R, Berckmans RJ, McGregor S, et al. Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. Blood 95: 930-935, 2000.
24. Larkin M. Raised endothelial microparticles an early marker for multiple sclerosis? Lancet 357: 1679, 2001.
25. Albert DA, Silverstein MD, Paunicka K, Reddy G, Chang RW, Derus C. The diagnosis of polyarteritis nodosa. II. Empirical verification of a decision analysis model. Arthritis Rheum 31: 1128-1134, 1988.
26. Albert DA, Rimon D, Silverstein MD. The diagnosis of polyarteritis nodosa. I. A literature-based decision analysis approach. Arthritis Rheum 31: 1117-1127, 1988.
27. Albert J, Ekoe JM. Angiographic aspects of polyarteritis nodosa. Rev Med Suisse Romande 103: 351-354, 1983.
28. Brogan PA, Davies R, Gordon I, Dillon MJ. Renal angiography in children with polyarteritis nodosa. Pediatr Nephrol 17: 277-283, 2002.
29. Brogan PA, Bose A, Burgner D, et al. Kawasaki disease: An evidence based approach to diagnosis, treatment, and proposals for future research. Arch Dis Child 86: 286-290, 2002.
30. Hagen EC, Daha MR, Hermans J, et al. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization. Kidney Int 53: 743-753, 1998.
31. Savage CO. ANCA-associated renal vasculitis. Kidney Int 60 1614-1627, 2001.
32. Kerr GS, Fleisher TA, Hallahan CW, Leavitt RY, Fauci AS, Hoffman GS. Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with Wegener's granulomatosis. Arthritis Rheum 36: 365-371, 1993.
33. Woywodt A, Streiber F, deGroot K, Regelsberger H, Haller H, Haubitz M. Circulating endothelial cells as markers for ANCA-associated small-vessel vasculitis. Lancet 361: 206-210, 2003.
34. Nakatani K, Takeshita S, Tsujimoto H, Kawamura Y, Tokutomi T, Sekine I. Circulating endothelial cells in Kawasaki disease. Clin Exp Immunol 131: 536-540, 2003.
35. Jimenez JJ, Wenche J, Mauro LM, Soderland C, Horstman LL, Ahn Y. Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis. Thromb Res 109: 175-180, 2003.